Results 191 to 200 of about 78,398 (259)

Correction: Dhillon et al. Molecular Insights and Therapeutic Advances in Low-Risk Myelodysplastic Neoplasms: A Clinical Review. <i>Cancers</i> 2025, <i>17</i>, 3610. [PDF]

Cancers (Basel)
Dhillon V, Maciejewski J, Balasubramanian SK.   +2 more
europepmc   +1 more source

CERA Detection and Stability in Blood Versus Urine. [PDF]

Drug Test Anal
Salamin O, Chappuis J, Bækken LV, Kuuranne T, Leuenberger N.   +4 more
europepmc   +1 more source

Association of erythropoietin gene polymorphism (rs1617640 C>T/G) with diabetic retinopathy in Type 2 diabetes mellitus patients of Punjabi population in Pakistan. [PDF]

PLoS One
Disoma C, Malik A, Nisar A, Ullah I, Hayat S, Qadeer A, Mehmood SA, Khan S, Xia Z.   +8 more
europepmc   +1 more source

Over eight years of transfusion independence with continuous erythropoietin receptor activator and Roxadustat in transfusion-dependent low-risk myelodysplastic syndrome. [PDF]

Oxf Med Case Reports
Ikenoue T, Furumatsu Y, Kitamura T.
europepmc   +1 more source

Neuroprotective effects of caffeine, erythropoietin, magnesium sulfate, and thyroxine in preterm infants: a network meta-analysis. [PDF]

Transl Pediatr
Wang Y, Wang S, Dou H, Zhang Y, Yang L.
europepmc   +1 more source

Comparison of administration of oral versus Infusions intravenous iron therapy in diabetic patients with chronic kidney disease receiving Erythropoietin. [PDF]

Pak J Med Sci
Din N, Durrani A, Nouman MK, Haider B.
europepmc   +1 more source

Effect of 2-h hypoxic exposure on resting hepcidin levels in young adults. [PDF]

Physiol Rep
Lin CA, Naruse M, Tomiishi C, Matsudo H, Badenhorst CE, Goto K.   +5 more
europepmc   +1 more source

The recombinant human erythropoietin: a brief review with emphasis in the process of quality control

, 2013
Michele Bruna de S. do NASCIMENTO, Clarice Lima do Canto Abreu, Rodrigo Henrique Ferreira [UNIFESP] Costa, Wlamir Corrêa de Moura, Isabella Fernandes Delgado   +4 more
openalex   +1 more source

Comparative effectiveness of darbepoetin vs other agents in chronic kidney disease-related anemia: a systematic review and network meta-analysis. [PDF]

BMC Nephrol
Hassan MF, Bin Faheem MS, Cheema S, Henna F, Javid S, Islam MR, Habib I, Usman M, Kurmasha YH, Samadi S, Mohammad YN.   +10 more
europepmc   +1 more source

Ginsenoside Rb1 attenuates erythropoietin-exacerbated vascular calcification in chronic kidney disease through BMP2-dependent Smad1/5/9 inhibition. [PDF]

Cytojournal
Li X, Xu Z, Li Y, Luo Y, Zhou J, Zuo D, Xiong W.   +6 more
europepmc   +1 more source